This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
N06DA04
1 out of 7 registries used, show all original rules.
1949
Check minimum number of events
Min. number of events
3
1949
Include endpoints None
1949
Remove individuals based on genotype QC
1873
ADMED_ACHEI_GALANTAMINE
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
First used in FinnGen datafreeze
DF2
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Use of galantamine
based on the number of shared cases.
Broader endpoints:
- Use of anticholinesterases
- N06DA Anticholinesterases
- Alzheimer’s disease, wide definition (more control exclusions)
- Alzheimer’s disease, wide definition
- Dementia
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1873 | 811 | 1062 |
| Unadjusted prevalence (%) | 0.45 | 0.35 | 0.58 |
| Mean age at first event (years) | 78.64 | 78.26 | 78.93 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: ADMED_ACHEI_GALANTAMINE – Use of galantamine
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Use of galantamine
↥Endpoint not on priority list, no data to show.